Meeting of the Advisory Commission on Childhood Vaccines

• Published date: 02 January 2020
• Citation: 85 FR 112
• Record Number: 2019-28294
• Section: Notices
• Court: Health And Human Services Department,Health Resources And Services Administration

Federal Register, Volume 85 Issue 1 (Thursday, January 2, 2020)

[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
                [Notices]
                [Pages 112-113]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-28294]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Health Resources and Services Administration
                Meeting of the Advisory Commission on Childhood Vaccines
                AGENCY: Health Resources and Services Administration (HRSA), Department
                of Health and Human Services (HHS).
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: In accordance with the Federal Advisory Committee Act, this
                notice announces that the Advisory Commission on Childhood Vaccines
                (ACCV) will hold public meetings for the 2020 calendar year (CY).
                Information about ACCV, agendas, and materials for these meetings can
                be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.
                DATES: ACCV meetings will be held on:
                 March 5-6, 2020;
                 June 4-5, 2020;
                 September 3-4, 2020; and
                 December 3-4, 2020.
                 These meetings will be held from 9:00 a.m.-5:00 p.m. Eastern Time.
                ADDRESSES: Meetings may be held in-person, by teleconference, and/or
                Adobe Connect webinar. In-person ACCV meetings will be held at 5600
                Fishers Lane, Rockville, Maryland 20857. Instructions for joining the
                meetings either in-person or remotely will be posted on the ACCV
                website 30 business days before the date of the meeting. For meeting
                information
                [[Page 113]]
                updates, go to the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.
                FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury
                Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville,
                Maryland 20857; 301-443-6634; or [email protected].
                SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations
                to the Secretary of HHS on policy, program development, and other
                issues related to implementation of the National Vaccine Injury
                Compensation Program (VICP) and concerning other matters as described
                under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
                19).
                 Agenda items and meeting times are subject to change as priorities
                dictate. Refer to the ACCV website listed above for any meeting updates
                that may occur. For CY 2020 meetings, agenda items may include, but are
                not limited to updates from: (1) The Division of Injury Compensation
                Programs; (2) Department of Justice; (3) Office of Infectious Disease
                and HIV/AIDS Policy (HHS); (4) Immunization Safety Office (Centers for
                Disease Control and Prevention); (5) National Institute of Allergy and
                Infectious Diseases (National Institutes of Health); and, (6) Center
                for Biologics, Evaluation and Research (Food and Drug Administration).
                Refer to the ACCV website listed above for all current and updated
                information concerning the CY 2020 ACCV meetings, including draft
                agendas and meeting materials that will be posted 5 calendar days
                before the meeting.
                 Members of the public will have the opportunity to provide
                comments. Public participants may submit written statements in advance
                of the scheduled meeting(s). Oral comments will be honored in the order
                they are requested and may be limited as time allows. Requests to
                submit a written statement or make oral comments to ACCV should be sent
                to Annie Herzog using the contact information above at least 5 business
                days before the meeting date(s).
                 Individuals who need special assistance or another reasonable
                accommodation should notify Annie Herzog using the contact information
                listed above at least 10 business days before the meeting(s) they wish
                to attend. Since all in person meetings will occur in a federal
                government building, attendees must go through a security check to
                enter the building. Non-U.S. Citizen attendees must notify HRSA of
                their planned attendance at least 20 business days prior to the meeting
                in order to facilitate their entry into the building. All attendees are
                required to present government-issued identification prior to entry.
                Maria G. Button,
                Director, Executive Secretariat.
                [FR Doc. 2019-28294 Filed 12-31-19; 8:45 am]
                 BILLING CODE 4165-15-P